BEAT BioTherapeutics’ Co-Founder, D. Michael Regnier, To Present At American College of Cardiology Annual Meeting
Published: Mar 28, 2014
BEAT BioTherapeutics Corporation (BEATBio) announced today that co-founder and Scientific Advisory Board member, Dr. Michael Regnier, will present at the upcoming American College of Cardiology Annual Scientific Sessions meeting on March 29, 2014 in Washington, D.C. Dr. Regnier is Professor and Vice Chairman of the Department of Bioengineering at the University of Washington. He also leads the Heart and Muscle Mechanics laboratory in the Department of Bioengineering and is an expert in cardiac and skeletal muscle physiology, muscle dysfunction with disease and development of gene and cell therapies.
Help employers find you! Check out all the jobs and post your resume.